Tetsuro Kamiya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tetsuro Kamiya has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Hirokazu Hara
Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University
30 shared publicationsTetsuo Adachi
Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan
25 shared publications- Hirokazu Hara
Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University
12 shared publications Junya Makino
Department of Biomedical Pharmaceutics, Laboratory of Clinical Pharmaceutics, and ‡Department of Organic and Medicinal Chemistry, Laboratory of Pharmaceutical Synthetic Chemistry, Gifu Pharmaceutical University , 1-25-4 Daigaku-nishi, Gifu 501-1196, Japan
8 shared publicationsNaoki Inagaki
6 shared publications- Tetsuo Adachi
Laboratory of Clinical Pharmaceutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan
6 shared publications
Latest Publications
- 8 June 2026
- Published by Taylor & Francis in Free Radical Research
- Vol. 60 (5) , 1-16
Acidic plasma-activated povidone-iodine induces copper-dependent oxidative death in oral squamous cell carcinoma cells
Oral squamous cell carcinoma (OSCC) requires therapeutic strategies that preserve oral function while providing effective tumor control. Here we demonstrate that non-thermal plasma (NTP) irradiation of a clinically established povidone-iodine solution generates a potent cytotoxic formulation termed plasma-activated povidone-iodine (PAI). PAI selectively reduced viability of OSCC cell lines (SAS, HSC-2, HSC-4) compared with normal fibroblasts. Mechanistically, PAI activity strictly depended on its acidic pH (3.0 or below) and hydrogen peroxide (H2O2) generated during NTP irradiation. Neutralization or freeze-drying abolished both H2O2 content and cytotoxicity, indicating that reactive oxygen species are essential mediators. Unlike plasma-activated media, whose effects are predominantly iron-dependent, PAI-induced cytotoxicity required intracellular monovalent copper (Cu+). The Cu+ chelator tetrathiomolybdate suppressed ROS accumulation, glutathione depletion, lipid peroxidation, and cell death, whereas classical ferroptosis or apoptosis inhibitors failed to rescue viability. PAI increased intracellular Cu+ levels and triggered oxidative damage including γH2AX induction; however, the resulting death program was mechanistically distinct from apoptosis, ferroptosis, and cuproptosis. Our findings reveal a previously unrecognized Cu+-dependent oxidative pathway initiated by PAI. This study establishes an accessible iodine-based platform that harnesses metal-driven redox chemistry for selective OSCC elimination.
- 8 June 2026
- Published by Taylor & Francis in Free Radical Research
- Vol. 60 (5) , 1-16
Acidic plasma-activated povidone-iodine induces copper-dependent oxidative death in oral squamous cell carcinoma cells
Oral squamous cell carcinoma (OSCC) requires therapeutic strategies that preserve oral function while providing effective tumor control. Here we demonstrate that non-thermal plasma (NTP) irradiation of a clinically established povidone-iodine solution generates a potent cytotoxic formulation termed plasma-activated povidone-iodine (PAI). PAI selectively reduced viability of OSCC cell lines (SAS, HSC-2, HSC-4) compared with normal fibroblasts. Mechanistically, PAI activity strictly depended on its acidic pH (3.0 or below) and hydrogen peroxide (H2O2) generated during NTP irradiation. Neutralization or freeze-drying abolished both H2O2 content and cytotoxicity, indicating that reactive oxygen species are essential mediators. Unlike plasma-activated media, whose effects are predominantly iron-dependent, PAI-induced cytotoxicity required intracellular monovalent copper (Cu+). The Cu+ chelator tetrathiomolybdate suppressed ROS accumulation, glutathione depletion, lipid peroxidation, and cell death, whereas classical ferroptosis or apoptosis inhibitors failed to rescue viability. PAI increased intracellular Cu+ levels and triggered oxidative damage including γH2AX induction; however, the resulting death program was mechanistically distinct from apoptosis, ferroptosis, and cuproptosis. Our findings reveal a previously unrecognized Cu+-dependent oxidative pathway initiated by PAI. This study establishes an accessible iodine-based platform that harnesses metal-driven redox chemistry for selective OSCC elimination.
- 2 January 2026
- Published by Taylor & Francis in Free Radical Research
- Vol. 60 (1) , 39-49
Non-thermal plasma prevents IgE-mediated Ca 2+ influx and allergic response in RBL-2H3 cells
Non-thermal plasma (NTP) has been reported to exhibit various biological effects, including hemostatic, anticancer, and wound-healing properties. However, the effects of NTP on allergic responses in mast cells and basophils have not been sufficiently investigated. In this study, we examined the effects of NTP on immunoglobulin E-mediated degranulation and cytokine expression in the basophilic cell line RBL-2H3. To induce degranulation and cytokine expression as part of allergic reactions, we treated the cells with 2,4-dinitrophenylated bovine serum albumin after sensitization or with the Ca2+ ionophore A23187. Cells were also treated with NTP-activated acetated Ringer's solution (PAA). Degranulation was measured by quantifying the β-hexosaminidase activity. PAA treatment inhibited both antigen stimulation- and A23187-induced degranulation in RBL-2H3 cells, and suppressed antigen-induced mRNA expression of cytokines, including IL-4, IL-6, and TNF-α. Antigen stimulation caused disintegration of the F-actin cytoskeleton, and PAA treatment suppressed these morphological changes. Cotreatment with PAA and catalase blocked the inhibitory effects of PAA on antigen stimulation-induced degranulation. PAA also inhibited A23187-induced extracellular signal-regulated kinase (ERK) phosphorylation and antigen stimulation- or store-operated Ca2+ entry inducer thapsigargin-induced cellular Ca2+ influx. These results indicate that PAA effectively inhibits immunological responses in allergic cells-such as degranulation and cytokine expression-by suppressing ERK phosphorylation and Ca2+ influx. These findings suggest that PAA may be an effective therapeutic option for treating patients with allergic diseases.
- 2 January 2026
- Published by Taylor & Francis in Free Radical Research
- Vol. 60 (1) , 39-49
Non-thermal plasma prevents IgE-mediated Ca 2+ influx and allergic response in RBL-2H3 cells
Non-thermal plasma (NTP) has been reported to exhibit various biological effects, including hemostatic, anticancer, and wound-healing properties. However, the effects of NTP on allergic responses in mast cells and basophils have not been sufficiently investigated. In this study, we examined the effects of NTP on immunoglobulin E-mediated degranulation and cytokine expression in the basophilic cell line RBL-2H3. To induce degranulation and cytokine expression as part of allergic reactions, we treated the cells with 2,4-dinitrophenylated bovine serum albumin after sensitization or with the Ca2+ ionophore A23187. Cells were also treated with NTP-activated acetated Ringer's solution (PAA). Degranulation was measured by quantifying the β-hexosaminidase activity. PAA treatment inhibited both antigen stimulation- and A23187-induced degranulation in RBL-2H3 cells, and suppressed antigen-induced mRNA expression of cytokines, including IL-4, IL-6, and TNF-α. Antigen stimulation caused disintegration of the F-actin cytoskeleton, and PAA treatment suppressed these morphological changes. Cotreatment with PAA and catalase blocked the inhibitory effects of PAA on antigen stimulation-induced degranulation. PAA also inhibited A23187-induced extracellular signal-regulated kinase (ERK) phosphorylation and antigen stimulation- or store-operated Ca2+ entry inducer thapsigargin-induced cellular Ca2+ influx. These results indicate that PAA effectively inhibits immunological responses in allergic cells-such as degranulation and cytokine expression-by suppressing ERK phosphorylation and Ca2+ influx. These findings suggest that PAA may be an effective therapeutic option for treating patients with allergic diseases.
- 2 September 2025
- Published by Taylor & Francis in Free Radical Research
- Vol. 59 (8-9) , 634-645
Copper induces cystine/glutamate antiporter SLC7A11 through the activation of Nrf2 and Atox1 pathways
Amino acid metabolism plays a crucial role in tumor biology. The sodium-independent cystine/glutamate exchange system, known as system Xc-, is significantly activated in cancer cells and plays a role in tumor progression. Copper (Cu), an essential micronutrient, plays a crucial role in physiological processes; however, its accumulation in tumors has been associated with tumor progression. Nonetheless, the relationship between system Xc--mediated amino acid metabolism and Cu remains inadequately understood. In this study, CuCl2 treatment resulted in the significant induction of SLC7A11, a light chain subunit of system Xc-, and glutamate receptor mGluR1 expression in human triple-negative MDA-MB-231 cells. Conversely, FeCl2 treatment induced the expression of SLC7A11 but not mGluR1, indicating that Cu specifically activated SLC7A11-mediated amino acid metabolism. The investigation focused on the role of Nrf2, a redox-sensitive transcription factor, in the induction of SLC7A11 under conditions of oxidative stress induced by CuCl2 treatment. Upon treatment with CuCl2, the nuclear translocation of Nrf2 was observed, and knockdown of Nrf2 significantly suppressed the induction of SLC7A11. Given that the Cu chaperone, antioxidant-1 (Atox1), functions as a Cu-dependent transcription factor, the role of Atox1 in the expression of SLC7A11 was further investigated. Like the effects of Nrf2 knockdown, Atox1 was found to play a pivotal role in the Cu-mediated induction of SLC7A11. Our findings indicate that intratumoral Cu influences the expression of SLC7A11 and may play a role in tumor progression.
- 2 September 2025
- Published by Taylor & Francis in Free Radical Research
- Vol. 59 (8-9) , 634-645
Copper induces cystine/glutamate antiporter SLC7A11 through the activation of Nrf2 and Atox1 pathways
Amino acid metabolism plays a crucial role in tumor biology. The sodium-independent cystine/glutamate exchange system, known as system Xc-, is significantly activated in cancer cells and plays a role in tumor progression. Copper (Cu), an essential micronutrient, plays a crucial role in physiological processes; however, its accumulation in tumors has been associated with tumor progression. Nonetheless, the relationship between system Xc--mediated amino acid metabolism and Cu remains inadequately understood. In this study, CuCl2 treatment resulted in the significant induction of SLC7A11, a light chain subunit of system Xc-, and glutamate receptor mGluR1 expression in human triple-negative MDA-MB-231 cells. Conversely, FeCl2 treatment induced the expression of SLC7A11 but not mGluR1, indicating that Cu specifically activated SLC7A11-mediated amino acid metabolism. The investigation focused on the role of Nrf2, a redox-sensitive transcription factor, in the induction of SLC7A11 under conditions of oxidative stress induced by CuCl2 treatment. Upon treatment with CuCl2, the nuclear translocation of Nrf2 was observed, and knockdown of Nrf2 significantly suppressed the induction of SLC7A11. Given that the Cu chaperone, antioxidant-1 (Atox1), functions as a Cu-dependent transcription factor, the role of Atox1 in the expression of SLC7A11 was further investigated. Like the effects of Nrf2 knockdown, Atox1 was found to play a pivotal role in the Cu-mediated induction of SLC7A11. Our findings indicate that intratumoral Cu influences the expression of SLC7A11 and may play a role in tumor progression.
- 17 February 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 994, 177391
Zinc treatment prevents IgE-mediated Ca2+ influx and allergic response in RBL-2H3 cells
- 17 February 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 994, 177391
Zinc treatment prevents IgE-mediated Ca2+ influx and allergic response in RBL-2H3 cells
- 15 February 2025
- Published by Taylor & Francis in Free Radical Research
- Vol. 59 (2) , 129-137
Involvement of iron ions in 6-hydroxydopamine-induced disruption of intracellular copper metabolism
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Recently, disorders in metabolism of metals, including copper (Cu) and iron (Fe), have been reported to be linked to the pathogenesis of PD. We previously demonstrated that 6-hydoroxydopamine (6-OHDA), a neurotoxin used for the production of PD model animals, decreases Atox1, a Cu chaperone, and ATP7A, a Cu transporter, and disrupts intracellular Cu metabolism in human neuroblastoma SH-SY5Y cells. However, the exact mechanisms remain unclear. Meanwhile, intracellular Fe modulates 6-OHDA-induced cellular responses. In this study, we investigated whether Fe participates in 6-OHDA-induced abnormality in Cu metabolism. 6-OHDA-induced reactive oxygen species (ROS) production and cellular injury were suppressed by Fe chelators, deferoxamine and 2,2'-bipyridyl (BIP). These chelators also restored 6-OHDA-induced degradation of Atox1 and ATP7A proteins and subsequent Cu accumulation, indicating that intracellular Fe is involved in the disruption of Cu homeostasis associated with 6-OHDA. Atox1 has redox-sensitive cysteine (Cys) residues in its Cu-binding site. The Cys residues of Atox1 were oxidized by 6-OHDA, and BIP suppressed their oxidation. Moreover, the replacement of Cys with histidine in the Cu-binding site conferred resistance to 6-OHDA-induced Atox1 degradation. These results suggest that oxidized modification of Atox1 by 6-OHDA is likely to accelerate its degradation. Thus, we conclude that Fe and Cu metabolisms are closely related to each other in the pathogenesis of PD.
- 15 February 2025
- Published by Taylor & Francis in Free Radical Research
- Vol. 59 (2) , 129-137
Involvement of iron ions in 6-hydroxydopamine-induced disruption of intracellular copper metabolism
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Recently, disorders in metabolism of metals, including copper (Cu) and iron (Fe), have been reported to be linked to the pathogenesis of PD. We previously demonstrated that 6-hydoroxydopamine (6-OHDA), a neurotoxin used for the production of PD model animals, decreases Atox1, a Cu chaperone, and ATP7A, a Cu transporter, and disrupts intracellular Cu metabolism in human neuroblastoma SH-SY5Y cells. However, the exact mechanisms remain unclear. Meanwhile, intracellular Fe modulates 6-OHDA-induced cellular responses. In this study, we investigated whether Fe participates in 6-OHDA-induced abnormality in Cu metabolism. 6-OHDA-induced reactive oxygen species (ROS) production and cellular injury were suppressed by Fe chelators, deferoxamine and 2,2'-bipyridyl (BIP). These chelators also restored 6-OHDA-induced degradation of Atox1 and ATP7A proteins and subsequent Cu accumulation, indicating that intracellular Fe is involved in the disruption of Cu homeostasis associated with 6-OHDA. Atox1 has redox-sensitive cysteine (Cys) residues in its Cu-binding site. The Cys residues of Atox1 were oxidized by 6-OHDA, and BIP suppressed their oxidation. Moreover, the replacement of Cys with histidine in the Cu-binding site conferred resistance to 6-OHDA-induced Atox1 degradation. These results suggest that oxidized modification of Atox1 by 6-OHDA is likely to accelerate its degradation. Thus, we conclude that Fe and Cu metabolisms are closely related to each other in the pathogenesis of PD.
- 2 January 2025
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 45 (1) , 73-82
Bortezomib suppresses TGF-β1-mediated LOXL4 reduction through the inhibition of MEK/ERK pathways in MDA-MB-231 cells
Lysyl oxidase (LOX), a copper-containing secretory oxidase, plays a key role in the regulation of extracellular stiffness through cross-linking with collagen and elastin. Among the LOX family of enzymes, LOX-like 4 (LOXL4) exhibits pro-tumor and anti-tumor properties; therefore, the functional role of LOXL4 in tumor progression is still under investigation. Here, we first determined that transforming growth factor-β1 (TGF-β1) significantly decreased LOXL4 expression in human breast cancer MDA-MB-231 cells, which suggested that decreased LOXL4 may participate in tumor progression. In this study, we also investigated how TGF-β1 decreases LOXL4 expression. TGF-β1-induced intracellular reactive oxygen species (ROS) played a role in LOXL4 protein expression but had no effect on LOXL4 mRNA levels. The proteasomal inhibitor, bortezomib, significantly suppressed TGF-β1-mediated LOXL4 reduction, which indicated that TGF-β1 facilitates LOXL4 proteasomal degradation. Furthermore, bortezomib inhibited TGF-β1-induced MEK/ERK pathways which are involved in LOXL4 reduction and TGF-β1-mediated cell migration. Finally, we also determined the potential role of N-glycosylation in LOXL4 secretion. We found that the dysregulation of N-glycosylation may be involved in the reduction in LOXL4 secretion. Overall, bortezomib is expected to inhibit TNBC progression by inhibiting both the MEK/ERK and proteasomal degradation pathways, which regulate LOXL4 expression.
- 2 January 2025
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 45 (1) , 73-82
Bortezomib suppresses TGF-β1-mediated LOXL4 reduction through the inhibition of MEK/ERK pathways in MDA-MB-231 cells
Lysyl oxidase (LOX), a copper-containing secretory oxidase, plays a key role in the regulation of extracellular stiffness through cross-linking with collagen and elastin. Among the LOX family of enzymes, LOX-like 4 (LOXL4) exhibits pro-tumor and anti-tumor properties; therefore, the functional role of LOXL4 in tumor progression is still under investigation. Here, we first determined that transforming growth factor-β1 (TGF-β1) significantly decreased LOXL4 expression in human breast cancer MDA-MB-231 cells, which suggested that decreased LOXL4 may participate in tumor progression. In this study, we also investigated how TGF-β1 decreases LOXL4 expression. TGF-β1-induced intracellular reactive oxygen species (ROS) played a role in LOXL4 protein expression but had no effect on LOXL4 mRNA levels. The proteasomal inhibitor, bortezomib, significantly suppressed TGF-β1-mediated LOXL4 reduction, which indicated that TGF-β1 facilitates LOXL4 proteasomal degradation. Furthermore, bortezomib inhibited TGF-β1-induced MEK/ERK pathways which are involved in LOXL4 reduction and TGF-β1-mediated cell migration. Finally, we also determined the potential role of N-glycosylation in LOXL4 secretion. We found that the dysregulation of N-glycosylation may be involved in the reduction in LOXL4 secretion. Overall, bortezomib is expected to inhibit TNBC progression by inhibiting both the MEK/ERK and proteasomal degradation pathways, which regulate LOXL4 expression.
- Open Access
- 1 January 2025
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 77 (2) , 153-161
Mallotus japonicus extract suppresses ferroptosis by inhibiting transferrin receptor-mediated ferrous ion uptake in human tubular epithelial HK2 cells
Iron (Fe) is the most abundant metal ion in the body, but its excess accumulation causes Fe2+-dependent and lipid peroxidation-dependent cell death (ferroptosis) via the production of reactive oxygen species (ROS). It is thought that ferroptosis is related to the progression of various kidney problems, including acute kidney injury and diabetic nephropathy. Mallotus japonicus (M. japonicus), a deciduous shrub belonging to the Euphorbiaceae family, contains ellagitannins such as corilagin, geraniin, mallotinic acid, and mallotusinic acid, which have antioxidant properties. Here, we investigated whether M. japonicus leaf extract inhibits ferroptosis in human proximal tubular epithelial HK2 cells. M. japonicus extract suppressed HK2 cell death caused by erastin, a ferroptosis inducer; this was accompanied by a reduction in intracellular Fe2+, ROS accumulation, and lipid peroxidation. Our findings suggested that the inhibitory effect of M. japonicus extract was due to the inhibition of transferrin receptor (CD71)-mediated Fe3+/2+ uptake. Furthermore, we determined that mallotinic acid is a key compound that exhibits anti-ferroptosis effects. Overall, our results provide useful information for the use of M. japonicus extract in the treatment of kidney injuries.
- 1 January 2025
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 77 (2) , 153-161
Open AccessMallotus japonicus extract suppresses ferroptosis by inhibiting transferrin receptor-mediated ferrous ion uptake in human tubular epithelial HK2 cells
Iron (Fe) is the most abundant metal ion in the body, but its excess accumulation causes Fe2+-dependent and lipid peroxidation-dependent cell death (ferroptosis) via the production of reactive oxygen species (ROS). It is thought that ferroptosis is related to the progression of various kidney problems, including acute kidney injury and diabetic nephropathy. Mallotus japonicus (M. japonicus), a deciduous shrub belonging to the Euphorbiaceae family, contains ellagitannins such as corilagin, geraniin, mallotinic acid, and mallotusinic acid, which have antioxidant properties. Here, we investigated whether M. japonicus leaf extract inhibits ferroptosis in human proximal tubular epithelial HK2 cells. M. japonicus extract suppressed HK2 cell death caused by erastin, a ferroptosis inducer; this was accompanied by a reduction in intracellular Fe2+, ROS accumulation, and lipid peroxidation. Our findings suggested that the inhibitory effect of M. japonicus extract was due to the inhibition of transferrin receptor (CD71)-mediated Fe3+/2+ uptake. Furthermore, we determined that mallotinic acid is a key compound that exhibits anti-ferroptosis effects. Overall, our results provide useful information for the use of M. japonicus extract in the treatment of kidney injuries.
- 24 June 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (26) , 14678-14683
Methoxylated Flavones from Casimiroa edulis La Llave Suppress MMP9 Expression via Inhibition of the JAK/STAT3 Pathway and TNFα-Dependent Pathways
Matrix metalloproteinase 9 (MMP9), an MMP isozyme, plays a crucial role in tumor progression by degrading basement membranes. It has therefore been proposed that the pharmacological inhibition of MMP9 expression or activity could inhibit tumor metastasis. We previously isolated two novel methoxylated flavones, casedulones A and B, from the leaves and/or roots of Casimiroa edulis La Llave and determined that these casedulones have antitumor activity that acts via the reduction of MMP9. Here, we examined how these casedulones suppress lipopolysaccharide (LPS)-induced MMP9 expression in human monocytic THP-1 cells. The casedulones suppressed the LPS-induced signal transducer and activator of transcription 3 (STAT3) pathway, which participates in MMP9 induction. In addition, AG490 and S3I-201, inhibitors of Janus kinase (JAK) and STAT3, suppressed LPS-mediated MMP9 induction, suggesting that the casedulones suppressed MMP9 induction through the inhibition of JAK/STAT3 pathways. Based on the findings that cycloheximide, an inhibitor of de novo protein synthesis, completely inhibited LPS-mediated MMP9 induction, the role of de novo proteins in MMP9 induction was further investigated. We found that the casedulones inhibited the induction of interleukin-6 (IL-6), a key inflammatory cytokine that participates in STAT3 activation. Moreover, tumor necrosis factor-α (TNFα)-mediated MMP9 induction was significantly suppressed in the presence of the casedulones. Taken together, these findings suggest that casedulones inhibit the IL-6/STAT3 and TNFα pathways, which all involve LPS-mediated MMP9 induction.
- 24 June 2024
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 72 (26) , 14678-14683
Methoxylated Flavones from Casimiroa edulis La Llave Suppress MMP9 Expression via Inhibition of the JAK/STAT3 Pathway and TNFα-Dependent Pathways
Matrix metalloproteinase 9 (MMP9), an MMP isozyme, plays a crucial role in tumor progression by degrading basement membranes. It has therefore been proposed that the pharmacological inhibition of MMP9 expression or activity could inhibit tumor metastasis. We previously isolated two novel methoxylated flavones, casedulones A and B, from the leaves and/or roots of Casimiroa edulis La Llave and determined that these casedulones have antitumor activity that acts via the reduction of MMP9. Here, we examined how these casedulones suppress lipopolysaccharide (LPS)-induced MMP9 expression in human monocytic THP-1 cells. The casedulones suppressed the LPS-induced signal transducer and activator of transcription 3 (STAT3) pathway, which participates in MMP9 induction. In addition, AG490 and S3I-201, inhibitors of Janus kinase (JAK) and STAT3, suppressed LPS-mediated MMP9 induction, suggesting that the casedulones suppressed MMP9 induction through the inhibition of JAK/STAT3 pathways. Based on the findings that cycloheximide, an inhibitor of de novo protein synthesis, completely inhibited LPS-mediated MMP9 induction, the role of de novo proteins in MMP9 induction was further investigated. We found that the casedulones inhibited the induction of interleukin-6 (IL-6), a key inflammatory cytokine that participates in STAT3 activation. Moreover, tumor necrosis factor-α (TNFα)-mediated MMP9 induction was significantly suppressed in the presence of the casedulones. Taken together, these findings suggest that casedulones inhibit the IL-6/STAT3 and TNFα pathways, which all involve LPS-mediated MMP9 induction.
- 3 March 2024
- Published by Taylor & Francis in Free Radical Research
- Vol. 58 (3) , 170-179
Inhibition of glutamine metabolism increases sensitivity to plasma-activated medium-induced cytotoxicity
Non-thermal atmospheric pressure plasma (NTP), an ionized gas containing electrons, ions, radicals, and photons, has various biological effects, including wound healing and anticancer effects. Plasma-activated medium (PAM), which is prepared by irradiating medium with NTP, preferentially kills cancer cells. Large amounts of reactive oxygen species (ROS) and reactive nitrogen species (RNS) included in PAM are closely related to its anticancer effects. The precise mechanism of PAM-induced cytotoxicity is not fully understood; however, PAM exposure has been reported to reduce cellular energy metabolism. Glutamine (Gln) is an important amino acid as an energy source in cancer cells. Gln is converted to glutamate by glutaminase (GLS), and is utilized to synthesize ATP and glutathione (GSH). Expression levels of GLS have been shown to be higher in certain types of cancers. In this study, we examined the effects of GLS inhibition on PAM cytotoxicity using breast cancer MDA-MB-231 cells. Pretreatment with BPTES, a glutaminase 1 (GLS1) inhibitor, dose-dependently enhanced PAM-induced cell death. PAM-induced ROS production and gamma-H2AX formation, a DNA damage marker, were increased in cells pretreated with BPTES compared with PAM alone. BPTES pretreatment enhanced a PAM-induced decrease in intracellular GSH, indicating the possibility that BPTES reduces the antioxidant capacity of MDA-MB-231 cells. In addition, BPTES pretreatment enhanced PAM-induced loss of the mitochondrial membrane potential and reduction of ATP production. Moreover, GLS1 knockdown promoted PAM-induced cell death. Taken together, the combination of GLS1 inhibitors such as BPTES is considered to be useful for enhancing the cytotoxic effects of PAM against cancer cells.
- 3 March 2024
- Published by Taylor & Francis in Free Radical Research
- Vol. 58 (3) , 170-179
Inhibition of glutamine metabolism increases sensitivity to plasma-activated medium-induced cytotoxicity
Non-thermal atmospheric pressure plasma (NTP), an ionized gas containing electrons, ions, radicals, and photons, has various biological effects, including wound healing and anticancer effects. Plasma-activated medium (PAM), which is prepared by irradiating medium with NTP, preferentially kills cancer cells. Large amounts of reactive oxygen species (ROS) and reactive nitrogen species (RNS) included in PAM are closely related to its anticancer effects. The precise mechanism of PAM-induced cytotoxicity is not fully understood; however, PAM exposure has been reported to reduce cellular energy metabolism. Glutamine (Gln) is an important amino acid as an energy source in cancer cells. Gln is converted to glutamate by glutaminase (GLS), and is utilized to synthesize ATP and glutathione (GSH). Expression levels of GLS have been shown to be higher in certain types of cancers. In this study, we examined the effects of GLS inhibition on PAM cytotoxicity using breast cancer MDA-MB-231 cells. Pretreatment with BPTES, a glutaminase 1 (GLS1) inhibitor, dose-dependently enhanced PAM-induced cell death. PAM-induced ROS production and gamma-H2AX formation, a DNA damage marker, were increased in cells pretreated with BPTES compared with PAM alone. BPTES pretreatment enhanced a PAM-induced decrease in intracellular GSH, indicating the possibility that BPTES reduces the antioxidant capacity of MDA-MB-231 cells. In addition, BPTES pretreatment enhanced PAM-induced loss of the mitochondrial membrane potential and reduction of ATP production. Moreover, GLS1 knockdown promoted PAM-induced cell death. Taken together, the combination of GLS1 inhibitors such as BPTES is considered to be useful for enhancing the cytotoxic effects of PAM against cancer cells.
- Open Access
- 1 January 2024
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 75 (1) , 1-6
Role of copper and SOD3-mediated extracellular redox regulation in tumor progression
Copper (Cu), an essential micronutrient, participates in several physiological processes, including cell proliferation and development. Notably, the disturbance of Cu homeostasis promotes tumor progression through the generation of oxidative stress. Chronic or excessive accumulation of reactive oxygen species (ROS) causes lipid peroxidation, protein denaturation, and enzyme inactivation, which leads to a breakdown of intracellular homeostasis and exacerbates tumor progression. The disruption of the ROS scavenging mechanism also reduces resistance to oxidative stress, leading to further deterioration in a disease state, and maintenance of redox homeostasis is thought to inhibit the onset and progression of various diseases. Superoxide dismutase 3 (SOD3), a Cu-containing secretory antioxidative enzyme, plays a key role in extracellular redox regulation, and the significant reduction in SOD3 facilitates tumor progression. Furthermore, the significant induction of SOD3 participates in tumor metastasis. This review focuses on the role of Cu homeostasis and antioxidative enzymes, including SOD3, in tumor progression, to help clarify the role of redox regulation.
- 1 January 2024
- Published by The Society for Free Radical Research Japan in Journal of Clinical Biochemistry and Nutrition
- Vol. 75 (1) , 1-6
Open AccessRole of copper and SOD3-mediated extracellular redox regulation in tumor progression
Copper (Cu), an essential micronutrient, participates in several physiological processes, including cell proliferation and development. Notably, the disturbance of Cu homeostasis promotes tumor progression through the generation of oxidative stress. Chronic or excessive accumulation of reactive oxygen species (ROS) causes lipid peroxidation, protein denaturation, and enzyme inactivation, which leads to a breakdown of intracellular homeostasis and exacerbates tumor progression. The disruption of the ROS scavenging mechanism also reduces resistance to oxidative stress, leading to further deterioration in a disease state, and maintenance of redox homeostasis is thought to inhibit the onset and progression of various diseases. Superoxide dismutase 3 (SOD3), a Cu-containing secretory antioxidative enzyme, plays a key role in extracellular redox regulation, and the significant reduction in SOD3 facilitates tumor progression. Furthermore, the significant induction of SOD3 participates in tumor metastasis. This review focuses on the role of Cu homeostasis and antioxidative enzymes, including SOD3, in tumor progression, to help clarify the role of redox regulation.